SmartRent, Inc. Form 8-K Summary
Business Context and Reporting Period
SmartRent, Inc. (NYSE: SMRT) filed this Current Report on Form 8-K on May 2, 2025. The filing addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the Company's compliance with continued listing standards. The Company is incorporated in Delaware and operates as an emerging growth company.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point disclosed is the average closing share price of the Company's Class A common stock, which was reported as less than $1.00 over a consecutive 30-trading-day period ending May 2, 2025.
Material Changes and Listing Status
- Delisting Notice: The Company received a notice from the NYSE stating it is not in compliance with Section 802.01C of the NYSE Listed Company Manual due to the low share price.
- Current Status: The Class A common stock remains listed and traded on the NYSE during the cure period.
- Cure Period: The Company has a six-month period from the date of the notice to regain compliance.
- Compliance Requirements: To regain compliance, the Company must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30-trading-day period ending on the last trading day of any calendar month within the cure period.
Outlook, Management Commentary, and Risks
Management intends to monitor the share price and evaluate options to resolve the deficiency, which may include effecting a reverse stock split, subject to Board and stockholder approval. The filing includes standard forward-looking statements cautioning that actual results may differ materially from expectations. The primary risk identified is the potential suspension and delisting of the Company's stock if compliance is not achieved within the six-month window.
Investor Verification Checklist
- Verify the current trading price and 30-day average of SMRT stock to assess proximity to the $1.00 threshold.
- Monitor upcoming Board of Directors meetings for any proposals regarding a reverse stock split.
- Review the Company's most recent Form 10-K (for the year ended December 31, 2024) for detailed financial health and liquidity status, as this 8-K does not provide those figures.
- Track the Company's progress toward the six-month cure deadline to avoid delisting.